Bluesight and ASHP collaboratively launch the Controlled Substances Diversion Prevention Program (CSDPP) assessment tool. Key functionalities of the tool include a survey of items to assess as best practice for the facility’s CSDPP, a comprehensive gap analysis and comparison across practice sites, means to organize and structure an action plan against diversion, and the customization and download of data sets for reporting outputs. The web-based resource is the result of a collaborative effort that spans more than a year and a half of testing, refinement, and the contributions of Bluesight’s clinical team, customers, and drug diversion leaders, working together with ASHP.